The patients who coped through summer on a light SPF and minimal moisturiser are about to struggle. Every autumn, I see the same pattern: rosacea subtype 1 patients, those with erythematotelangiectatic rosacea (ETR), whose skin held reasonably well through humid months start presenting with increased reactivity, tightness, and baseline redness from October onwards.
The mechanism is the same every year. Transepidermal water loss rises as ambient humidity falls. The impaired lipid barrier that characterises ETR loses ground. Central heating removes what outdoor air still provided. The skin enters a cycle of barrier breakdown and inflammatory response that takes weeks to settle once established.
The right time to intervene is now, in September, before the cycle starts.
Why rosacea skin behaves differently in autumn
Patients with ETR and papulopustular rosacea (PPR) have a structurally compromised skin barrier compared to unaffected skin. Ceramide fractions are reduced, particularly ceramide 1, and baseline transepidermal water loss is measurably higher than in matched controls. In summer, ambient humidity partially compensates. In autumn, that compensation disappears.
The practical consequence is that products tolerated in July may trigger burning and stinging by November. The patient's experience of their own skin changes, and the advice needs to change with it.
A second autumn-specific factor is the move back to central heating. Heated indoor air has very low relative humidity. Patients spending more hours in heated environments get a compounding effect on TEWL that cannot be addressed by changing their skincare routine alone.
The four questions I ask every September
When I see a rosacea patient between September and mid-October, I work through four specific questions before anything else:
- What moisturiser are you currently using, and does it go on morning and evening without fail?
- Have you noticed any tightness, increased flushing, or burning in cooler or windier weather in previous autumns?
- Is your SPF formulation mineral or chemical, and is it one that your skin has always tolerated?
- Are you using retinoids, alpha-hydroxy acids, or any vitamin C actives at concentration?
The answers tell me how much barrier support the patient already has and where the risk sits. A patient who is two months into tretinoin, washing with a foaming cleanser, and wearing a chemical SPF is carrying three sources of barrier stress into winter. Identifying all three in September gives time to adjust before the flares start.
What the evidence supports
The NICE Clinical Knowledge Summary for rosacea recommends gentle, non-foaming cleansers and emollient moisturisers as standard care across all subtypes. The British Association of Dermatologists' rosacea guidance notes that environmental triggers account for a significant proportion of reported flares, with temperature change and wind among the most frequently cited.
For ETR specifically, formulations containing ceramides and niacinamide reduce subjective sensitivity and support the barrier over time. These are not cosmetic additions to treatment. They are part of managing the condition in a climate where four months of the year actively challenge skin barrier integrity.
The JCCP standards of practice framework asks practitioners to demonstrate ongoing clinical decision-making for patients under their care. A barrier-specific seasonal consultation is consistent with that expectation.
Adjusting prescribing for PPR in cooler months
For PPR patients already on azelaic acid 15%, autumn is the time to reinforce application technique. Applying the acid on a well-moisturised base and following with a second layer of emollient where needed significantly improves local tolerance in dry weather. I advise patients to treat their azelaic acid as sandwiched between layers rather than applied to bare skin.
PPR patients on topical ivermectin 1% (Soolantra) should continue year-round, but September is a useful point to confirm adherence. Some patients reduce frequency in summer when lesion counts fall, then present in October with a flare that stems from undertreating through August.
A practical autumn protocol for your rosacea patients
The intervention I recommend to practitioners is simple. Before mid-October, review your active rosacea patient list. A short written note, through your usual communication channel, covers four points: check their cleanser is fragrance-free and non-foaming; confirm they are using a ceramide moisturiser morning and evening without exception; encourage a switch to mineral SPF if they are not already on one; reduce retinoid frequency or pause temporarily if their skin is currently reactive.
The conversation takes under five minutes in a review appointment. Sending a note to patients takes longer to draft than to act on. Done now, in September, it prevents a season of reactive appointments and distressed skin from November through January.
Rosacea management is not just reactive. The most effective practices I know treat it as an ongoing relationship between appointments. The September barrier conversation is part of that.
The full clinical framework for rosacea subtype assessment, barrier function, and treatment selection is covered in depth in the Rosacea Beyond Redness course at aestheticsunlocked.co.uk/courses/rosacea-beyond-redness.